Key takeawaysShort on time? Just read this part
- Oral GLP-1 medications are mostly still at the research stage and do not yet have as much long-term data as injectable Mounjaro
- The side effects of Mounjaro are mainly gastrointestinal symptoms such as nausea and diarrhea, but in rare cases symptoms requiring caution, such as gallbladder disease and pancreatitis, have also been reported
- In short, at present it is injectable Mounjaro that has the most complete data on efficacy and safety
What you will learn in this article
- Differences in effects, mechanisms, and side effects between Mounjaro (injection) and oral medications such as Rybelsus
- Typical weight loss reported in clinical trials, and individual variation
- Points for safe use
Introduction: a new option in medical weight loss—”injection” or “oral”?
In medical weight loss using GLP-1/GIP receptor agonists, injectable Mounjaro has the most data on effectiveness and safety, while oral medications are still being developed as a future option. “No diet ever worked for me before, and I can’t believe how easily I’m losing weight with medical help.” Comments of surprise like this are increasing in cosmetic dermatology and internal medicine clinics.
At the center of this is medical weight loss (medical diet) using “GLP-1 receptor agonists.” These drugs, once used at the forefront of diabetes treatment, have been recognized for their strong appetite-suppressing and metabolism-improving effects, and have now become a standard option for “losing weight scientifically.”
However, when it comes time to start, many people face the same dilemma: “Should I choose an injection like Mounjaro, or an oral medication like Rybelsus?”
“Injections look painful, but I feel they might work better.” “Pills are easy, but do they really make you lose weight?” In this article, we thoroughly compare and explain the mechanisms, differences in weight-loss effects, convenience, and risk of side effects, focusing on Mounjaro, the latest GIP/GLP-1 receptor agonist, and Rybelsus, an oral medication.
Get the knowledge here that will serve you for life as you take the shortest route to your ideal figure.
Note that Mounjaro (tirzepatide) was originally approved as a treatment for type 2 diabetes. In Japan, use for weight loss or cosmetic purposes is self-pay treatment (not covered by health insurance; you pay the full cost). Because the cost structure differs from insurance-covered care for diabetes treatment, be sure to confirm the total cost during your consultation at the clinic.
What is Mounjaro? How it works and its features
Mounjaro (tirzepatide) is a once-weekly injectable “dual agonist” that acts on two hormones, GLP-1 and GIP, at the same time, with stronger appetite-suppressing and blood-sugar-improving effects than conventional GLP-1-only drugs. Mounjaro is a medication injected once a week. Its generic name is “tirzepatide,” and it is a “dual agonist” that mimics the actions of two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
GLP-1 is a hormone secreted from the small intestine that lowers blood sugar and suppresses appetite.
GIP is also a hormone secreted from the digestive tract; it helps insulin secretion and improves energy metabolism.
A key feature of Mounjaro is that by stimulating both at the same time, it provides greater “blood sugar control” and “appetite suppression” than conventional GLP-1 drugs.
Effects of injectable Mounjaro: how much weight loss it achieves
In a 72-week clinical trial, Mounjaro was reported to produce an average weight loss of 15–20%, a greater weight-loss effect than existing GLP-1-only drugs. Mounjaro’s effects have been confirmed in large clinical trials in people with obesity and diabetes.
- In a trial in which it was used for 72 weeks (about a year and a half), data showed an average weight loss of 15–20%. For example, for a person weighing 100 kg, that works out to a loss of 15–20 kg.
- This is stronger than conventional GLP-1 drugs (such as semaglutide), and in a head-to-head trial Mounjaro also showed greater weight loss.
In addition to weight, effects such as “a large reduction in waist size,” “improved blood sugar control,” and “reduced strain on the heart” have also been reported.
However, the 15–20% figure is only the average among clinical trial participants. The amount of weight lost varies from person to person depending on age, constitution, lifestyle, and dose, and not everyone will get the same results. The actual effect needs to be assessed while monitoring your progress during consultations with your doctor.
Comparison with oral GLP-1 medications
Oral GLP-1 medications are mostly still at the research stage and do not yet have as much long-term data as injectable Mounjaro. Meanwhile, “oral” versions are being developed for people who are reluctant to have injections. A representative example is a drug called orforglipron. It is still at the research stage, but it is expected to have a weight-loss effect similar to that of injections.
At present, however,
- many oral medications have not yet been approved, and data are limited
- it is not yet fully known whether their effects are stable or whether they are safe in the long term
—these are some of the challenges.
Key point
Therefore, at present it can be said that “injectable Mounjaro is the option with the most established data.”
Side effects and precautions
The side effects of Mounjaro are mainly gastrointestinal symptoms such as nausea and diarrhea, but in rare cases symptoms requiring caution, such as gallbladder disease and pancreatitis, have also been reported. Every medication has advantages and disadvantages. Mounjaro and other GLP-1 drugs share some common side effects.
4.1 Common side effects
- Nausea
- Diarrhea or constipation
- Loss of appetite
- Abdominal bloating or discomfort
These tend to occur because the drug acts on the digestive tract and are most noticeable early on, but in many cases the body gets used to it within a few weeks.
4.2 Side effects requiring caution
- Slightly increased risk of gallstones and gallbladder disease
- Cases of pancreatitis have been reported
- An association with thyroid tumors has been suggested in animal studies, so people with a relevant medical history need to be careful
To reduce the risk of side effects, regular blood tests and imaging tests under a doctor’s guidance are recommended.
Differences between injections and oral medications: summary
In short, at present it is injectable Mounjaro that has the most complete data on efficacy and safety. The table below summarizes what we have covered so far in terms of administration, effects, and side effects.
| Item | Mounjaro (injection) | Oral type (in development) |
|---|---|---|
| Administration | Subcutaneous injection once weekly | Expected to be taken daily |
| Effects | 15–20% weight loss confirmed | Promising, but data are limited |
| Side effects | Nausea and gastrointestinal symptoms are common | Similar side effects are expected |
| Long-term data | Many clinical trials | More data needed in the future |
| Convenience | Not suited to people who dislike injections | Ease of taking is an advantage |
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
Points to keep in mind when using Mounjaro
Using Mounjaro under a doctor’s supervision, together with diet and exercise, lets you get the most out of it while keeping it safe.
- Never use it on your own judgment; always see a doctor
- Using it together with a nutritionally balanced diet and moderate exercise increases its effect
- Have regular blood tests (liver function, kidney function, pancreatic enzymes, etc.) to confirm safety
- If side effects are severe, have your dose adjusted
Weight loss is not achieved by medication alone. Combining it with lifestyle changes helps prevent weight regain and maintain healthy weight loss. First, talk with a doctor in a free consultation about the approach that suits your constitution and wishes.

Recommended reading: A doctor’s detailed comparison of Mounjaro, Ozempic, and Saxenda
Research evidence
Mounjaro’s weight-loss effect is supported by several large clinical trials, including SURMOUNT-1, and peer-reviewed papers.
- The SURMOUNT-1 trial (NEJM, 2022) reported an average weight loss of nearly 20% in the Mounjaro group.
- A head-to-head trial against semaglutide (NEJM, 2025) confirmed Mounjaro’s superiority.
- A meta-analysis (PMC, 2023) showed a dose-dependent weight-loss effect at 5–15 mg.
- Studies in patients with heart failure or diabetes have also reported a reduction in cardiovascular risk.
Summary so far
Mounjaro has a strong weight-loss effect, but continuous supervision by a specialist is essential to manage side effects. Mounjaro (injection) has a stronger weight-loss effect than previous GLP-1 drugs and is opening up new possibilities in obesity treatment. On the other hand, it has side effects such as nausea and diarrhea, and there are also concerns about effects on the gallbladder and pancreas, so use under a specialist’s supervision is essential.
Oral GLP-1 medications are promising as a future option, but long-term data are still lacking at this stage. Therefore, it can be said that at present “Mounjaro (injection) is the option whose effectiveness and safety have been reliably demonstrated.”
Even when used for weight loss, medication is only one part of medical care. Combining it with nutritional guidance and exercise therapy allows for healthier, more sustainable weight loss.
When our editorial team reviewed several medical information programs and doctors’ explanatory videos on this topic, a point they had in common was a warning about “using Mounjaro obtained through personal importation or resale, which has become a hot topic on social media.” Medications obtained without a doctor’s examination have no guarantee of their ingredient content or quality, and cases leading to health problems have been reported in the news. As those responsible for researching and writing for our clinic, we also feel that any route other than a prescription from a legitimate clinic should be avoided.
Recommended reading: Mounjaro injections: self-pay treatment and the medical rules
The future of oral GLP-1 medications and the outlook ahead
Several pharmaceutical companies are developing oral GLP-1 medications as a next-generation option that removes the psychological hurdle of injections. Injectable drugs are highly effective, but there are psychological hurdles such as “reluctance to have injections” and “worry about handling needles.” In response, several pharmaceutical companies are currently developing “oral GLP-1 medications.”
8.1 Advantages of oral medications
- Simple—you just take it every day
- No need for injection training at a medical facility
- Easy to carry when traveling or going out
They have a major advantage in terms of how easily they fit into daily life.
8.2 Future challenges
- Whether they can deliver sustained, stable effects
like injections - Whether long-term safety can be adequately confirmed
- The issue of medication adherence (continuity) with daily dosing
If these challenges are overcome, oral medications will likely become established as “the second option after Mounjaro.”
Monitoring needed with long-term use of Mounjaro
When using Mounjaro long term, regular monitoring with blood tests, imaging tests, and body composition measurement is key to ensuring safety. Mounjaro is highly effective, but long-term use requires regular tests and consultations. The following points are considered especially important.
9.1 Blood tests
Liver and kidney function
Check that there is no strain on the organs involved in metabolism and excretion
Pancreatic enzymes (amylase and lipase)
Detect the risk of pancreatitis early
Lipids and blood sugar
Assess overall improvement in lifestyle-related diseases
9.2 Imaging tests
Because abnormalities tend to appear in the gallbladder and pancreas, an abdominal ultrasound may be performed as needed.
9.3 Body composition measurement
It is recommended to measure not only body weight but also muscle mass and fat mass. This is because if rapid weight loss causes you to lose muscle as well, your basal metabolism drops and the risk of weight regain increases.
Precautions when using Mounjaro
To use Mounjaro safely, it is important to follow three principles: get it by prescription through legitimate channels, improve your lifestyle, and consult early if side effects occur. To use Mounjaro safely, you need to pay attention to the following points.
Do not obtain it through personal importation or online shopping without a doctor’s prescription
→ There is a risk of harm to your health from counterfeit drugs or inappropriate doses.
Improve your lifestyle at the same time
→ Relying on medication alone makes weight regain more likely and leads to loss of muscle mass and a lower metabolism.
Consult a doctor early if side effects occur
→ Mild nausea or diarrhea may be temporary, but severe or persistent symptoms are a warning sign.
Take a long-term view
→ It is important to think about weight management over one or two years and to discuss with your doctor when to stop or switch medications.
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
Patient experiences
Looking at trends among Mounjaro users, people describe not only the weight loss but also how they dealt with gastrointestinal symptoms in the early stage. Referring to the voices of people who have actually used Mounjaro gives a more concrete picture of its effects and precautions. The following are illustrative examples based on trends commonly reported in clinical practice, not testimonials from specific, named individuals. Effects and side effects vary from person to person, so please read these as reference information only.
Woman in her 40s (BMI 32)
“I lost 15 kg in a year. The nausea was hard at first, but my body gradually got used to it. Now my body feels lighter, and my blood sugar has returned to normal.”
Man in his 50s (with diabetes)
“I was scared of injections at first, but the injection pen was easy. Losing weight also lowered my blood pressure, and I’m on fewer medications now.”
Woman in her 30s
“It certainly helps you lose weight, but feeling full after just a little food when eating out was actually stressful. It’s best to talk carefully with your doctor about how to use it.”
As these experiences show, the effects can be significant, but balancing it with your life and dealing with side effects are important.
Expert views
Specialists value Mounjaro’s strong weight-loss effect, while emphasizing the importance of assessing suitability and monitoring for side effects. Specialists in obesity and diabetes treatment have given the following assessments of Mounjaro.
- “Compared with conventional drugs, its weight-loss effect is in a class of its own“
- “However, it is not suitable for everyone, and a doctor’s assessment of suitability is essential“
- “With long-term use, monitoring for side effects and support for lifestyle improvement are indispensable”
Key point
In other words, Mounjaro is not a “magic drug”; it is positioned strictly as one part of medical support.
About self-pay treatment and off-label use
Frequently asked questions (FAQ)
We answer questions patients often ask about the effects, insurance coverage, and side effects of Mounjaro and oral medications. We have compiled questions patients often ask when choosing between Mounjaro and oral medications.
QWhich helps you lose more weight, Mounjaro or Rybelsus?
According to current clinical data, injectable Mounjaro tends to produce greater average weight loss. However, individual differences are large and some people do better with oral medication, so please consult your doctor based on your constitution and lifestyle.
QIs Mounjaro covered by health insurance?
It may be covered by health insurance when used to treat diabetes, but use for weight loss or cosmetic purposes is self-pay treatment, and you pay the full cost.
QI’m scared of injections. How painful are they?
The needle is very thin, and how much pain people feel varies. If strong pain persists, talk to your doctor about rotating injection sites and your injection technique.
QWhen will oral medications become available?
As of July 2026, these drugs are mostly at the research and development stage, and no specific approval date has been set. For the latest approval status, check announcements from the pharmaceutical companies and the PMDA (Pharmaceuticals and Medical Devices Agency, Japan).
QWhat should I do if I get side effects?
Mild nausea and diarrhea are common early symptoms, but if symptoms are severe or persistent, don’t just put up with them on your own judgment—contact your prescribing doctor promptly.
QIs it okay to buy it cheaply through personal importation?
Personally imported products have no guarantee of their ingredient content or quality, and health problems have been reported. Always see a doctor and get a prescription from a legitimate clinic.
Not sure? Talk to us
No consultation fee (first & follow-up visits)Online consultation available
Toll-free 0120-241-929 (toll-free in Japan, 9:00–18:00 JST, Japanese only)
Summary: comparing the future of injections and oral medications
At present, the most reliable option is injectable Mounjaro, while oral medications are being developed as a strong future option.
Mounjaro (injection)
→ Currently has the most data on effectiveness and safety and achieves strong weight loss. Managing side effects is key.
Oral type (in development)
→ A strong future option. Highly convenient, but evidence is still lacking.
Common points
→ Must be combined with diet and exercise. Significant results can be expected when used under a doctor’s supervision.
Conclusion
Subcutaneously injected Mounjaro has shown results far exceeding previous obesity drugs. If oral GLP-1 medications become available in the future, it will likely become easier for even more people to choose treatment.
Key point
However, whichever you choose, the most important thing is to “use it safely, under a doctor’s supervision, together with lifestyle improvements.” Mounjaro is not “magic for losing weight”; it is one powerful option for regaining your health.
References
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387:205-216. (SURMOUNT-1 trial)
- Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). New England Journal of Medicine. 2025;393(1):26-36.
- Ma J, Liu M, Wang R, et al. Efficacy and safety of tirzepatide in people with type 2 diabetes by baseline body mass index: an exploratory subgroup analysis of SURPASS-AP-Combo. Diabetes Obesity and Metabolism. 2024;26(4):1454-1463.
- Frías JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine. 2021;385:503-515.
- American Diabetes Association (ADA). Standards of Medical Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl.1). (For clinical guidelines in Japan, see the Japan Diabetes Society.)
- U.S. Food and Drug Administration (FDA). Mounjaro (tirzepatide) Prescribing Information. 2022. Drug safety information in Japan is also available from the Pharmaceuticals and Medical Devices Agency (PMDA).
- European Medicines Agency (EMA). Assessment report: Mounjaro (tirzepatide). 2022.
Who to contact if you have side effects | When to see a doctor
If you have any of the following symptoms, contact us rather than waiting to see how things go on your own. GIP/GLP-1 receptor agonists, including Mounjaro, are known to have side effects, mainly gastrointestinal symptoms. Most are mild, but rarely they can be serious.
| Symptoms | Possible cause | What to do |
|---|---|---|
| Persistent nausea and vomiting | Gastrointestinal symptoms. The most common side effect | Contact us if you continue to be unable to keep fluids down |
| Severe abdominal pain (pain radiating to the back) | Suspected acute pancreatitis | Stop the medication immediately and see a doctor |
| Cold sweats, palpitations, intense hunger, feeling confused or drowsy | Hypoglycemia | Take some sugar right away and contact us |
| Skin rash, difficulty breathing, swelling of the face or throat | Allergic reaction | See a doctor immediately |
If your symptoms are severe outside these hours, go to your nearest emergency medical facility.
Direct phone numbers for each clinic are listed on the clinic information page.
References
The information about medications in this article is based on the following official sources. For details on dosage and administration and side effects, always check the latest electronic package insert.
Pharmaceuticals and Medical Devices Agency (PMDA): “Mounjaro Subcutaneous Injection Ateos—Electronic Package Insert”
PMDA: “Drug Guide for Patients: Mounjaro Subcutaneous Injection Ateos” (PDF)
Ministry of Health, Labour and Welfare (Japan): “Prevention of Lifestyle-Related Diseases”
Use of Mounjaro for purposes other than obesity disease is self-pay treatment and is not covered by public health insurance. Effects and side effects vary from person to person.
Medically reviewed by: Dr. Hiroko Oka (Chair, Fukubikai Medical Corporation; Certified Member, Japanese Society of Internal Medicine)



